Applications of nanoparticles in biomedical imaging

Xiangjun Han, Ke Xu, Olena Taratula, Khashayar Farsad

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.

Original languageEnglish (US)
Pages (from-to)799-819
Number of pages21
JournalNanoscale
Volume11
Issue number3
DOIs
StatePublished - Jan 21 2019

Fingerprint

Nanoparticles
Imaging techniques
Contrast Media
Magnetic resonance imaging
Fluorescence
Tissue
Microstructure

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Applications of nanoparticles in biomedical imaging. / Han, Xiangjun; Xu, Ke; Taratula, Olena; Farsad, Khashayar.

In: Nanoscale, Vol. 11, No. 3, 21.01.2019, p. 799-819.

Research output: Contribution to journalReview article

Han, Xiangjun ; Xu, Ke ; Taratula, Olena ; Farsad, Khashayar. / Applications of nanoparticles in biomedical imaging. In: Nanoscale. 2019 ; Vol. 11, No. 3. pp. 799-819.
@article{6ac0156232ac40cd88762212e7874942,
title = "Applications of nanoparticles in biomedical imaging",
abstract = "An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.",
author = "Xiangjun Han and Ke Xu and Olena Taratula and Khashayar Farsad",
year = "2019",
month = "1",
day = "21",
doi = "10.1039/c8nr07769j",
language = "English (US)",
volume = "11",
pages = "799--819",
journal = "Nanoscale",
issn = "2040-3364",
publisher = "Royal Society of Chemistry",
number = "3",

}

TY - JOUR

T1 - Applications of nanoparticles in biomedical imaging

AU - Han, Xiangjun

AU - Xu, Ke

AU - Taratula, Olena

AU - Farsad, Khashayar

PY - 2019/1/21

Y1 - 2019/1/21

N2 - An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.

AB - An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85060123914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060123914&partnerID=8YFLogxK

U2 - 10.1039/c8nr07769j

DO - 10.1039/c8nr07769j

M3 - Review article

VL - 11

SP - 799

EP - 819

JO - Nanoscale

JF - Nanoscale

SN - 2040-3364

IS - 3

ER -